Navigation path

PILGRIM


Preventing community and nosocomial spread and Infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance
EC contribution
: € 2,993,728
Duration
: 36 months
Starting date
: 01/01/2009
Funding scheme
: Small or medium-scale focused research project
Keywords
: infection control, nosocomial infection, antimicrobial resistance, Staphylococcus aureus
Contract/Grant agreement number
: 223050
Project web-site
: www.fp7-pilgrim.eu

Summary:

Methicillin-resistant Staphylococcus aureus (MRSA), also known as super bug, are of increasing concern both as community- and hospital-acquired infection. The PILGRIM project will provide novel control measures for the accelerated identification and control of resistant bacteria initially emerging from animals in order to prevent and eradicate community-acquired and nosocomial infections. Our hypothesis is that deeper understanding of factors affecting pathogen-host interaction of resistant bacteria at the molecular as well as the population level will lead to new and more effective control measures against nosocomial infection.

Problem:

Methicillin-resistant Staphylococcus aureus (MRSA) are of increasing concern both as community- and hospital-acquired pathogens. Since 2005, a specific clone, MRSA ST398 is spreading both in livestock populations and occupationally-exposed people resulting in human infection and disease in several EU Member States.

[+] Read More